Strategic Family Wealth Counselors’s Anavex Life Sciences AVXL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$24.7K Buy
+8,045
New +$34.8K 0.01% 161
2025
Q4
Sell
-7,545
Closed -$67.2K 219
2025
Q3
$67.2K Hold
7,545
0.02% 157
2025
Q2
$69.6K Buy
7,545
+27
+0.4% +$230 0.02% 145
2025
Q1
$64.5K Buy
+7,518
New +$71K 0.02% 136

Other funds holding AVXL

Strategic Family Wealth Counselors's AVXL Position: Q1 2026 in Review

Strategic Family Wealth Counselors opened a new position in Anavex Life Sciences (AVXL) in Q1 2026: 8,045 shares worth $24.7K. The stake represents 0.01% of the portfolio and ranks #161 among its holdings. This is a return to the name: Strategic Family Wealth Counselors previously reported a position in AVXL as recently as Q3 2025.

Strategic Family Wealth Counselors first reported a position in AVXL in Q1 2025 and has held it in 4 quarters since. The position peaked at $69.6K in Q2 2025. 190 funds tracked by Wall St. Rank hold AVXL as of Q1 2026.

  • Strategic Family Wealth Counselors held 8,045 shares of Anavex Life Sciences worth $24.7K as of Q1 2026.
  • Anavex Life Sciences was a new Strategic Family Wealth Counselors position in Q1 2026.
  • Anavex Life Sciences made up 0.01% of Strategic Family Wealth Counselors's portfolio in Q1 2026, its #161 holding.
  • Strategic Family Wealth Counselors first reported a position in Anavex Life Sciences in Q1 2025 and has held it in 4 quarters since.
  • Strategic Family Wealth Counselors's Anavex Life Sciences position peaked at $69.6K in Q2 2025.
  • 190 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q1 2026.

Based on Strategic Family Wealth Counselors's 13F filing for Q1 2026, filed 11 May 2026.